Press Releases

Lexicon Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on November 1, 2018	Oct 25, 2018
Lexicon Pharmaceuticals and Ipsen Biopharmaceuticals Canada Inc. Announce Health Canada Approval of Xermelo® (telotristat Ethyl) for the Treatment of Refractory Carcinoid Syndrome Diarrhea in Combination with Somatostatin Analog Therapy	Oct 16, 2018
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 54th Annual Meeting	Sep 24, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Sep 24, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Aug 30, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Aug 22, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Jul 31, 2018
Lexicon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides a Business Update	Jul 30, 2018
Lexicon Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018	Jul 23, 2018
Lexicon Pharmaceuticals Announces Positive 52-week Results from Sotagliflozin inTandem1 Study Presented at ADA 2018 and Published in Diabetes Care	Jun 24, 2018